Agreement has been reached with Roche Diagnostics France, to provide a new range of sequencing technologies for the Sequencing and Genotyping platform of the Institut du Cerveau – ICM. With this partnership, researchers of the Institut du Cerveau – ICM will have access to the most recent techniques for high throughput sequencing from the Applied Science range from Roche.
The agreement provides for a close cooperation from Roche engineers to renew and maintain state of the art genotyping and sequencing equipment for Institut du Cerveau – ICM groups and to share their expertise in the optimal organisation of sample and data streams.